N
NeMedIO
New take on the traditional industry of medical device and regulatory consulting
About NeMedIO
Nemedio operates in the medical device industry, providing comprehensive compliance solutions tailored for modern teams. The company offers a suite of tools and services designed to streamline the entire product development lifecycle, from initial ideation and prototyping to regulatory compliance and commercialization. Nemedio's platform is particularly beneficial for companies developing combination products, such as drug-device combinations, wearables, implantables, and software as a medical device (SaMD). By offering a unified set of tools, Nemedio helps clients navigate the complexities of regulatory pathways, ensuring that their products meet FDA and other regulatory standards. The business model revolves around a subscription-based service, where clients pay for access to the platform and additional support services. This model ensures a steady revenue stream while providing clients with ongoing support and updates. Nemedio primarily serves small to medium-sized enterprises (SMEs) in the medical device sector, helping them mitigate go-to-market risks and accelerate their product development timelines. The company makes money through subscription fees, consulting services, and software add-ons.
Source: Dealroom company dataAt a glance
- Founded
- 2017
- Headquarters
- New York City, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Downtown Brooklyn Partnership
Story Ventures
Eniac Ventures
Bowery Capital
Series A4 investors entered at this stage
Notation Capital- NCNeu Venture Capital
Charge Ventures
Supernode Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NeMedIO on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NeMedIO on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.